@taina_bongiee: So pweeedy #mrprice #polkadress @Mr Price fashion

taina_bongiee
taina_bongiee
Open In TikTok:
Region: ZA
Friday 21 August 2026 15:11:45 GMT
443627
73144
183
2877

Music

Download

Comments

lebo.t.mo
Lebo motloung🐘 :
I hid one at one Mr price I hope they dont find it😭 I need that dress
2026-08-23 08:01:36
1627
kmalahlela
kmalahlela :
Hear me out🥹
2026-08-24 15:08:22
375
itschampagnemamiii_
𝓞𝓷𝓴𝓪𝓱 💎 :
Okay thanks, now delete this😭
2026-08-23 16:12:47
131
iampaba11o
pabi. :
Delete this 😔💔
2026-08-23 16:36:26
615
prettyfacewaffles5
iHateMen♡. :
at which mrp is this dress❤️😩
2026-08-22 10:53:22
169
__nnete
c l e m e n t i n e :
I love these kind of dresses, but my breasts won't let me shine! 😭
2026-08-24 21:16:31
145
badgalmuhle
Tshepobothatakeng? :
Tjo I can’t live without it 😭
2026-08-22 15:22:25
30
ongyg1
OngyG :
bought myself this baby today and I’m in love🥹❤️
2026-08-24 13:41:46
40
amandagwelane209
amanda :
how much?
2026-08-22 10:13:32
34
crafts_byluh
luh :
2026-08-24 13:52:34
34
bontle_nl
Bontle :
Is this in white only? would love it in pink ❤️
2026-08-23 11:43:30
5
cnerh.radebe
MaBhungane🎀 :
Listen!!😭❤️
2026-08-27 11:36:24
12
cherline457
Tjelle :
I'm inlove with this dress ❤️
2026-08-22 22:14:27
5
chantelle.chirimu
Chantelle Chirimuta :
Mammie 🔥🤭❤️
2026-08-28 07:47:04
0
p.hemelo__
C.👷‍♀️ 🐣 :
😭Only downside is that they are see through
2026-08-31 11:31:37
2
linda_mavundla
linda_mavundla :
The only sizes left are XXL,I’m so hurt 😭😭
2026-09-01 22:03:53
1
sihle3274
Sihle ❤️ :
I took the chocolate brown instead of this one
2026-08-30 12:01:50
3
mabitsa_
Penny :
What a beautiful dress 😍 waist is snatched 😍😍
2026-08-23 15:52:01
1
thick_mimie
Mimie 💕 :
I got mine 😁🔥
2026-08-23 13:42:06
0
necoles_ugc
Nicky S✨ :
Gorgeous 🔥
2026-08-23 06:29:08
0
To see more videos from user @taina_bongiee, please go to the Tikwm homepage.

Other Videos

Are GLP-1 receptor agonists (like semaglutide and tirzepatide) doing more than just driving weight loss and glycemic control? Emerging observational studies and clinical trials suggest they may reduce the incidence of obesity-associated cancers and improve overall survival in active cancer patients! Let's break down the scientific mechanisms: 🩺🫁👇
 
 Hi, I'm Dr. Cleo Riles, Harvard-trained cancer researcher and science communicator. Welcome to Part 1 of my ongoing GLP-1s & Cancer Research Series:
 
 🧬 1. THE METABOLIC & TUMOR INTERSECTION:
 
 13 Obesity-Associated Cancers: Obesity drives chronic low-grade inflammation, hyperinsulinemia, elevated IGF-1 (insulin-like growth factor 1), and altered adipokines (leptin/adiponectin ratio)—all of which promote tumor cell proliferation and angiogenesis.
 
 Direct vs. Indirect Pathways: GLP-1s lower cancer risk indirectly through substantial adiposity loss and improved insulin sensitivity. However, researchers are also investigating direct GLP-1 receptor signalling in immune cells (e.g., NK cell restoration) and tumor microenvironments.
 
 📊 2. WHAT THE EARLY SIGNALS SHOW:
 
 Incidence Reduction: Large retrospective cohort studies show significant risk reductions in colorectal, pancreatic, endometrial, ovarian, and breast cancers compared to traditional anti-diabetic medications like insulin or sulfonylureas.
 
 Active Cancer Outcomes: Emerging studies are evaluating whether GLP-1 use during or after active treatment improves recurrence-free survival (RFS) and treatment response (e.g., reversing chemotherapy resistance driven by metabolic dysfunction).
 
 🔬 3. WHAT TO WATCH FOR IN THIS SERIES:
 Over the next several weeks, I'll be breaking down landmark studies, real-world comparative effectiveness data, and my own upcoming research presentation on GLP-1 use and breast cancer outcomes!
 
 👇 What questions do you have about GLP-1 medications and cancer risks? Leave them below!
 #GLP1 #Oncology #CancerResearch #Ozempic #Wegovy
Are GLP-1 receptor agonists (like semaglutide and tirzepatide) doing more than just driving weight loss and glycemic control? Emerging observational studies and clinical trials suggest they may reduce the incidence of obesity-associated cancers and improve overall survival in active cancer patients! Let's break down the scientific mechanisms: 🩺🫁👇 Hi, I'm Dr. Cleo Riles, Harvard-trained cancer researcher and science communicator. Welcome to Part 1 of my ongoing GLP-1s & Cancer Research Series: 🧬 1. THE METABOLIC & TUMOR INTERSECTION: 13 Obesity-Associated Cancers: Obesity drives chronic low-grade inflammation, hyperinsulinemia, elevated IGF-1 (insulin-like growth factor 1), and altered adipokines (leptin/adiponectin ratio)—all of which promote tumor cell proliferation and angiogenesis. Direct vs. Indirect Pathways: GLP-1s lower cancer risk indirectly through substantial adiposity loss and improved insulin sensitivity. However, researchers are also investigating direct GLP-1 receptor signalling in immune cells (e.g., NK cell restoration) and tumor microenvironments. 📊 2. WHAT THE EARLY SIGNALS SHOW: Incidence Reduction: Large retrospective cohort studies show significant risk reductions in colorectal, pancreatic, endometrial, ovarian, and breast cancers compared to traditional anti-diabetic medications like insulin or sulfonylureas. Active Cancer Outcomes: Emerging studies are evaluating whether GLP-1 use during or after active treatment improves recurrence-free survival (RFS) and treatment response (e.g., reversing chemotherapy resistance driven by metabolic dysfunction). 🔬 3. WHAT TO WATCH FOR IN THIS SERIES: Over the next several weeks, I'll be breaking down landmark studies, real-world comparative effectiveness data, and my own upcoming research presentation on GLP-1 use and breast cancer outcomes! 👇 What questions do you have about GLP-1 medications and cancer risks? Leave them below! #GLP1 #Oncology #CancerResearch #Ozempic #Wegovy

About